Anika Therapeutics | Валовая Прибыль





Валовая прибыль Изменить Дата
Abbott USD 6.54B 625M 2025-12
Agenus USD 23.93M 2.79M 2025-03
Agios Pharmaceuticals USD 11.2M 448K 2025-09
Anika Therapeutics USD 14.68M 9.46M 2025-03
Arrowhead Research USD 256.47M 228.7M 2025-09
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Heron Therapeutics USD 23.35M 1.6M 2024-09
Insmed USD 111.44M 33.36M 2025-09
Integra LifeSciences USD 206.99M 2.34M 2025-09
Intrexon USD -297K 167K 2024-06
J&J USD 16.6B 118M 2025-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Ligand Pharmaceuticals USD 155.28M 82.42M 2025-09
MacroGenics USD 61.25M 88.71M 2025-09
Merit Medical Systems USD 184.49M 12.47M 2025-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.45B 1.31B 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD -11.54M 3.99M 2024-09
Veracyte USD 91.28M 1.51M 2025-09
Xencor USD 21M 22.61M 2025-09
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12


Anika Therapeutics Валовая Прибыль - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Feb 2026.